Research on Complex Generics
Agency: Food and Drug Administration
Assistance Listings
- 93.103 -- Food and Drug Administration Research
Open opportunityLast Updated: Nov 13, 2026
Important dates
- Closing: December 14, 2026
Award details
- Expected project funding: Not specified
- Expected awards: 1
Award min.
$0
Award max.
$2,500,000
- Funding opportunity number:RFA-FD-27-001
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Agriculture
- Consumer protection
- Food and nutrition
- Health
- Category Explanation:Not specified
History
- Posted date: November 13, 2026
- Archive date: January 13, 2027
- Version: 2
Summary
Jump to documentsThe purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.
Eligibility
Miscellaneous
- Other
Additional information on eligibility
Only the following applicant is eligible to apply for this single source funding: The University of Maryland
Documents
| File name | Description | Last updated |
|---|---|---|
| Full_Announcement_RFA-FD-27-001.pdf | Full Notice of Funding Opportunity Announcement RFA-FD-27-001 | Nov 13, 2026 10:22 PM UTC |
Agency contact information
Email: patrick.johnson@fda.hhs.gov
patrick.johnson@fda.hhs.gov
Patrick Johnson
Grants Management Specialist
Food and Drug Administration
Link to additional information
No additional information is available
